These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8094214)

  • 41. The management of preterm premature rupture of the membranes near the limit of fetal viability.
    Waters TP; Mercer BM
    Am J Obstet Gynecol; 2009 Sep; 201(3):230-40. PubMed ID: 19733274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amnioinfusion for prevention of pulmonary hypoplasia in second-trimester rupture of membranes.
    Vergani P; Locatelli A; Strobelt N; Mariani S; Cavallone M; Arosio P; Ghidini A
    Am J Perinatol; 1997 Jul; 14(6):325-9. PubMed ID: 9217952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prevention of meconium aspiration in labor using amnioinfusion.
    Wenstrom KD; Parsons MT
    Obstet Gynecol; 1989 Apr; 73(4):647-51. PubMed ID: 2927860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe midtrimester oligohydramnios: treatment strategies.
    Kozinszky Z; Sikovanyecz J; Pásztor N
    Curr Opin Obstet Gynecol; 2014 Apr; 26(2):67-76. PubMed ID: 24614021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 15-Hydroxyprostaglandin dehydrogenase protein expression in human fetal membranes with and without subclinical inflammation.
    Rizek RM; Watson CS; Keating S; Tai HH; Challis JR; Bocking AD
    Reprod Sci; 2007 Apr; 14(3):260-9. PubMed ID: 17636240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcervical amnioinfusion.
    Vincent C; Hickok D
    J Am Board Fam Pract; 1993; 6(1):43-8. PubMed ID: 8421928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amnioinfusion in the evaluation of fetal obstructive uropathy: the effect of antibiotic prophylaxis on complication rates.
    Feldman B; Hassan S; Kramer RL; Kasperski SB; Evans MI; Johnson MP
    Fetal Diagn Ther; 1999; 14(3):172-5. PubMed ID: 10364669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The experience of amnioinfusion for oligohydramnios during the early second trimester.
    Hsu TL; Hsu TY; Tsai CC; Ou CY
    Taiwan J Obstet Gynecol; 2007 Dec; 46(4):395-8. PubMed ID: 18182345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Amnio-infusion, a technique worth developing].
    Kauffmann E; Chatelet-Cheront C; Guérin du Masgenêt B; Delcroix M
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(5):573-4. PubMed ID: 7499751
    [No Abstract]   [Full Text] [Related]  

  • 50. [Continuous amnioinfusion in premature rupture of membranes].
    Machalski T; Tomala J; Bakon I; Domagała S; Magnucki J; Chromy G; Kapek T
    Ginekol Pol; 2000 Aug; 71(8):742-5. PubMed ID: 11082914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment by autologous amniopatch of premature rupture of membranes following mid-trimester amniocentesis.
    Mandelbrot L; Bourguignat L; Mellouhi IS; Gavard L; Morin F; Bierling P
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):245-6. PubMed ID: 19009547
    [No Abstract]   [Full Text] [Related]  

  • 52. Prelabour rupture of the membranes--why hurry?
    Duncan SL; Beckley S
    Br J Obstet Gynaecol; 1992 Jul; 99(7):543-5. PubMed ID: 1525091
    [No Abstract]   [Full Text] [Related]  

  • 53. [Antenatal management in case of preterm premature rupture of membranes before fetal viability: CNGOF Preterm Premature Rupture of Membranes Guidelines].
    Azria E
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):1076-1088. PubMed ID: 30409732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Perinatal outcomes and duration of preterm premature rupture of membranes].
    Pieta-Dolińska A; Oszukowski P
    Ginekol Pol; 2005 Jun; 76(6):443-7. PubMed ID: 16149261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of midtrimester oligohydramnios: a case for amnioinfusion.
    Stringer M; Librizzi R; Weiner S
    J Perinatol; 1990 Jun; 10(2):143-5. PubMed ID: 2358897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amniopatch for iatrogenic rupture of the fetal membranes.
    Deprest J; Emonds MP; Richter J; DeKoninck P; Van Mieghem T; Van Schoubroeck D; Devlieger R; De Catte L; Lewi L
    Prenat Diagn; 2011 Jul; 31(7):661-6. PubMed ID: 21656529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of Preterm Premature Rupture of Membranes with Oligo-/Anhydramnion Colonized by Multiresistant Bacteria with Continuous Amnioinfusion and Antibiotic Administrations through a Subcutaneously Implanted Intrauterine Port System: A Case Report.
    Tchirikov M; Zhumadilov Z; Winarno AS; Haase R; Buchmann J
    Fetal Diagn Ther; 2017; 42(1):71-76. PubMed ID: 26447923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of PPROM with anhydramnion in humans: first experience with different amniotic fluid substitutes for continuous amnioinfusion through a subcutaneously implanted port system.
    Tchirikov M; Bapayeva G; Zhumadilov ZSh; Dridi Y; Harnisch R; Herrmann A
    J Perinat Med; 2013 Nov; 41(6):657-63. PubMed ID: 23774012
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Biochemical changes in extracellular matrix components of the amniotic sac during its premature rupture].
    Rechberger T; Postawski K; Donica H; Surmacz L; Jakowicki J
    Ginekol Pol; 1996 Mar; 67(3):117-24. PubMed ID: 8647503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amnioinfusion-induced malpresentation.
    Washburne JF; Chauhan SP; Magann EF; Moore JL; Morrison JC
    J Miss State Med Assoc; 1998 Jul; 39(7):240-1. PubMed ID: 9670704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.